Murine intramyocellular lipids quantified by NMR act as metabolic biomarkers in burn trauma

International Journal of Molecular Medicine

Volumn 21, Issue 6, 2008, Pages 825-832

  Tzika, A Aria ^a,c   Astrakas, Loukas G ^a   Cao, Haihui ^a   Mintzopoulos, Dionyssios ^a,c   Zhang, Qunhao ^a,c   Padfield, Katie ^a,c   Yu, Hongue ^a   Mindrinos, Michael N ^b   Rahme, Laurence G ^c   Tompkins, Ronald G ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Biomarkers; Burn trauma; Lipids; Metabolism; Mitochondria; Nuclear magnetic resonance; PGC 1 ; Skeletal muscle

Indexed keywords

ANTILIPEMIC AGENT; FATTY ACID; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; BIOLOGICAL MARKER; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; PPARGC1A PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SURFACE; BURN; CONTROLLED STUDY; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; DRUG DETERMINATION; DRUG EFFICACY; EX VIVO STUDY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOLYSIS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MOUSE; MUSCLE METABOLISM; MUSCLE MITOCHONDRION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; BIOLOGICAL MODEL; BLOOD; DNA MICROARRAY; GENETICS; HINDLIMB; HUMAN; METABOLISM; MITOCHONDRION; MUSCLE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REGRESSION ANALYSIS; ULTRASTRUCTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BIOLOGICAL MARKERS; BODY SURFACE AREA; BURNS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION PROFILING; GLUCOSE TRANSPORTER TYPE 4; GLYCOLYSIS; HINDLIMB; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; MUSCLE FIBERS; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REGRESSION ANALYSIS; TRANS-ACTIVATORS;

EID: 47649104060     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.6.825     Document Type: Article

References (50)

1. Meislin H, Criss EA, Judkins D, et al: Fatal trauma: the modal distribution of time to death is a function of patient demographics and regional resources. J Trauma 43: 433-440, 1997.
2. Meel BL: Incidence and patterns of violent and/or traumatic deaths between 1993 and 1999 in the Transkei region of South Africa. J Trauma 57: 125-129, 2004.
3. Ikezu T, Okamoto T, Yonezawa K, Tompkins RG and Martyn JA: Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J Biol Chem 272: 25289-25295, 1997.
4. Astrakas LG, Goljer I, Yasuhara S, et al: Proton NMR spectroscopy shows lipids accumulate in skeletal muscle in response to burn trauma-induced apoptosis. FASEB J 19: 1431-1440, 2005.
5. Padfield KE, Astrakas LG, Zhang Q, et al: Burn injury causes mitochondrial dysfunction in skeletal muscle. Proc Natl Acad Sci USA 102: 5368-5373, 2005.
6. Muller MJ and Herndon DN: The challenge of burns. Lancet 343: 216-220, 1994.
7. Deitch EA: The management of burns. N Engl J Med 323: 1249-1253, 1990.
8. Roden M, Price TB, Perseghin G, et al: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865, 1996.
9. McGarry JD: Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7-18, 2002.
10. Spiegelman BM and Heinrich R: Biological control through regulated transcriptional coactivators. Cell 119: 157-167, 2004.
11. Handschin C and Spiegelman BM: Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 27: 728-735, 2006.
12. Kressler D, Schreiber SN, Knutti D and Kralli A: The PGC-1-related protein PERC is a selective coactivator of estrogen receptor alpha. J Biol Chem 277: 13918-13925, 2002.
13. Lin J, Handschin C and Spiegelman BM: Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 1: 361-370, 2005.
14. Szczepaniak LS, Babcock EE, Schick F, et al: Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276: E977-E989, 1999.
15. Kuhlmann J, Neumann-Haefelin C, Belz U, Kramer W, Juretschke HP and Herling AW: Correlation between insulin resistance and intramyocellular lipid levels in rats. Magn Reson Med 53: 1275-1282, 2005.
16. Boesch C, Slotboom J, Hoppeler H and Kreis R: In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37: 484-493, 1997.
17. Schick F, Eismann B, Jung WI, Bongers H, Bunse M and Lutz O: Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 29: 159-167, 1993.
18. Neumann-Haefelin C, Kuhlmann J, Belz U, et al: Determinants of intramyocellular lipid concentrations in rat hindleg muscle. Magn Reson Med 50: 242-248, 2003.
19. Hwang JH, Pan JW, Heydari S, Hetherington HP and Stein DT: Regional differences in intramyocellular lipids in humans observed by in vivo 1H-MR spectroscopic imaging. J Appl Physiol 90: 1267-1274, 2001.
20. Krssak M, Petersen KF, Dresner A, et al: Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42: 113-116, 1999.
21. Jacob S, Machann J, Rett K, et al: Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48: 1113-1119, 1999.
22. Goodpaster BH, He J, Watkins S and Kelley DE: Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
23. Anderwald C, Bernroider E, Krssak M, et al: Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51: 3025-3032, 2002.
24. Sinha R, Dufour S, Petersen KF, et al: Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51: 1022-1027, 2002.
25. Tomera JF and Martyn J: Systemic effects of single hindlimb burn injury on skeletal muscle function and cyclic nucleotide levels in the murine model. Burns Incl Therm Inj 14: 210-219, 1988.
26. Yasuhara S, Perez ME, Kanakubo E, et al: Skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am J Physiol Endocrinol Metab 279: E1114-E1121, 2000.
27. Lee K, Berthiaurne F, Stephanopoulos GN, Yarmush DM and Yarmush ML: Metabolic flux analysis of postburn hepatic hypermetabolism. Metab Eng 2: 312-327, 2000.
28. Morvan D, Demidem A, Papon J, De Latour M and Madelmont JC: Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Cancer Res 62: 1890-1897, 2002.
29. Tzika AA, Cheng LL, Goumnerova L, et al: Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. J Neurosurg 96: 1023-1031, 2002.
30. Griffin JL, Lehtimaki KK, Valonen PK, et al: Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death. Cancer Res 63: 3195-3201, 2003.
31. Griffin JL and Shockcor JP: Metabolic profiles of cancer cells. Nat Rev Cancer 4: 551-561, 2004.
32. Griffin JL and Kauppinen RA: A metabolomics perspective of human brain tumours. FEBS J 274: 1132-1139, 2007.
33. Tzika AA, Astrakas L, Cao H, et al: Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med 20: 199-208, 2007.
34. Johnson AB, Argyraki M, Thow JC, Cooper BG, Fulcher G and Taylor R: Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man. Clin Sci 82: 219-226, 1992.
35. Perseghin G, Scifo P, De Cobelli F, et al: Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48: 1600-1606, 1999.
36. Galster AD, Bier DM, Cryer PE and Monafo WW: Plasma palmitate turnover in subjects with thermal injury. J Trauma 24: 938-945, 1984.
37. Pratt VC, Tredget EE, Clandinin MT and Field CJ: Fatty acid content of plasma lipids and erythrocyte phospholipids are altered following bum injury. Lipids 36: 675-682, 2001.
38. Mootha VK, Lindgren CM, Eriksson KF, et al: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273, 2003.
39. Petersen KF, Dufour S, Befroy D, Garcia R and Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004.
40. Cree MG and Wolfe RR: Post burn trauma insulin resistance and fat metabolism. Am J Physiol Endocrinol Metab 294: E1-E9, 2008.
41. Steiner G, Morita S and Vranic M: Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes 29: 899-905, 1980.
42. Reaven GM, Hollenbeck C, Jeng CY, Wu MS and Chen YD: Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024, 1988.
43. Dresner A, Laurent D, Marcucci M, et al: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidyl-inositol 3-kinase activity. J Clin Invest 103: 253-259, 1999.
44. Le Marchand-Brustel Y, Jeanrenaud B and Freychet P: Insulin binding and effects in isolated soleus muscle of lean and obese mice. Am J Physiol 234: E348-E358, 1978.
45. Molloy RG, O'Riordain M, Holzheimer R, et al: Mechanism of increased tumor necrosis factor production after thermal injury. Altered sensitivity to PGE2 and immunomodulation with indomethacin. J Immunol 151: 2142-2149, 1993.
46. Yonezawa K, Ando A, Kaburagi Y, et al: Signal transduction pathways from insulin receptors to Ras. Analysis by mutant insulin receptors. J Biol Chem 269: 4634-4640, 1994.
47. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF and Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271: 665-668, 1996.
48. St-Pierre J, Lin J, Krauss S, et al: Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 278: 26597-26603, 2003.
49. Cree MG, Zwetsloot JJ, Hemdon DN, et al: Insulin sensitivity and mitochondrial function are improved in children with bum injury during a randomized controlled trial of fenofibrate. Ann Surg 245: 214-221, 2007.
50. Sener G, Sehirli AO, Gedik N and Dulger GA: Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs. Burns 33: 587-593, 2007.